|
Volumn 14 Suppl 3, Issue , 2013, Pages
|
Pathway analysis of genome-wide data improves warfarin dose prediction.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYP2C9 PROTEIN, HUMAN;
MENADIONE EPOXIDASE;
MIXED FUNCTION OXIDASE;
UNSPECIFIC MONOOXYGENASE;
WARFARIN;
AFRICAN AMERICAN;
ARTICLE;
BIOLOGICAL MODEL;
CAUCASIAN;
DOSE RESPONSE;
GENE LINKAGE DISEQUILIBRIUM;
GENETIC ASSOCIATION;
GENETICS;
GENOTYPE;
HUMAN;
HUMAN GENOME;
METABOLISM;
METHODOLOGY;
SINGLE NUCLEOTIDE POLYMORPHISM;
AFRICAN AMERICANS;
ARYL HYDROCARBON HYDROXYLASES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
GENOME, HUMAN;
GENOME-WIDE ASSOCIATION STUDY;
GENOTYPE;
HUMANS;
LINKAGE DISEQUILIBRIUM;
METABOLIC NETWORKS AND PATHWAYS;
MIXED FUNCTION OXYGENASES;
MODELS, GENETIC;
POLYMORPHISM, SINGLE NUCLEOTIDE;
WARFARIN;
MLCS;
MLOWN;
|
EID: 84885410983
PISSN: None
EISSN: 14712164
Source Type: None
DOI: 10.1186/1471-2164-14-s3-s11 Document Type: Article |
Times cited : (14)
|
References (0)
|